Literature DB >> 11898947

Ephedra/ephedrine: cardiovascular and CNS effects.

Eric Wooltorton, Barbara Sibbald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11898947      PMCID： PMC99410     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Voluntary recall of ephedra products not enough, MD says.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Authors:  C A Haller; N L Benowitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 176.079
  2 in total
  4 in total

1.  "Lose 40 pounds in 4 weeks": regulating commercial weight-loss programs.

Authors:  Yoni Freedhoff; Arya M Sharma
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 2.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Witches, potions, and metabolites: an overview from a medicinal perspective.

Authors:  Luana Canzian Llanes; Nathalia Biazotto Sa; Arthur Ribeiro Cenci; Kerolain Faoro Teixeira; Igor Vinícius de França; Lidiane Meier; Aldo Sena de Oliveira
Journal:  RSC Med Chem       Date:  2022-03-30

Review 4.  Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine.

Authors:  Swapnil P Borse; Devendra P Singh; Manish Nivsarkar
Journal:  Porto Biomed J       Date:  2019-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.